Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LUMASIRAN vs LUMATEPERONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LUMASIRAN vs LUMATEPERONE: Safety Overview

Metric LUMASIRAN LUMATEPERONE
Total FAERS Reports 279 4,979
Deaths Reported 15 41
Death Rate 5.4% 0.8%
Hospitalizations 99 397
Average Patient Age 43.3 yrs 42.4 yrs
% Female Patients 72.7% 67.6%
FDA Approval Date Nov 23, 2020 Apr 22, 2022
Manufacturer Alnylam Pharmaceuticals, Inc. Intra-Cellular Therapies, Inc
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription